Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

FromKeeping Current CME


Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

FromKeeping Current CME

ratings:
Length:
31 minutes
Released:
Feb 26, 2021
Format:
Podcast episode

Description

In this activity, three experts discuss how to incorporate immune checkpoint inhibitor therapy into the management of individuals classified as part of the “special population” of patients not generally included in clinical trials. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/946383?src=mkm_podcast_addon_946383
Released:
Feb 26, 2021
Format:
Podcast episode

Titles in the series (100)

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.